ArticleInternational journal of biological sciences2025

Signature-based repurposed drugs resemble the inhibition of TGFβ-induced NDRG1 as potential therapeutics for triple-negative breast cancer.

Araceli López-Tejada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.